Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000695600 | SCV000824110 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2021-07-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val268Argfs*131) in the MED25 gene. It is expected to result in an absent or disrupted protein product. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MED25 cause disease. This variant has not been reported in the literature in individuals with MED25-related disease. This variant is present in population databases (rs775072432, ExAC 0.01%). |
Mayo Clinic Laboratories, |
RCV001507963 | SCV001713828 | uncertain significance | not provided | 2019-07-15 | criteria provided, single submitter | clinical testing |